204 results

Sun
Regulation Value

Posted on 28.05.2009

Heat and quite a lot of light

The sweltering heat and fever pitch of the football supporters contrasts starkly with the measured debate at the 2009 International Medical Device Industry Compliance, Regulatory and Intellectual Property Conference here in Rome. The Champions League final sees football shirted supporters rubbing shoulders with suited captains of industry in an unlikely melange. One item of news […]

By John Wilkinson Former Chief Executive of Eucomed

collaboration
Global

Posted on 06.05.2009

MassMEDIC Annual Meeting: Reflections on industry clinician collaboration

Sitting on Boston’s south shore, the John F. Kennedy Pesidential Library is both imposing yet not over-stated. A rare treat for me was the opportunity to address the annual meeting of MassMEDIC, the largest regional medical technology association in the USA – and that means the world, I am sure! The speaker’s podium has a […]

By John Wilkinson Former Chief Executive of Eucomed

Press-release
Regulation Value

Posted on 10.04.2009

Eucomed press release 05/09 – Revised Directive on Late payments: 23.6 billion Euros of unpaid invoices threaten small companies’ survival and jeopardize public health

Brussels, 8 April 2009 – Eucomed welcomes revision of directive 2000/35/EC on Late Payments adopted by the European Commission today strengthening current payment obligations. Association disappointed to see final text considerably watered down compared to initial clear targets. As the voice of the medical technology industry in Europe, Eucomed is extremely pleased to see late […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

nanotechnology
Access Regulation

Posted on 07.04.2009

More from the DIA EuroMeeting 2009

From 23 – 25 March 2009, the Drug Information Association (DIA) held its annual EuroMeeting in Berlin. During the presentation by Richard Moore, Institute of Nanotechnology, I learned that prescription drugs prove to be ineffective in 30% – 60% of patients1 and that 16% of the drugs approved in the USA are linked to severe […]

By Dario Pirovano Consultant Regulatory Affairs

Complex
Global Regulation

Posted on 24.03.2009

The role of EMEA in future regulation: consensus amongst experts

It was with some trepidation that I placed myself in the ‘lions  den’ of the pharmaceutical industry at the annual Euromeeting of the Drug Information Association in Berlin today. Sharing a platform to discuss the evolution of medical device regulation with Mdme Georgette Lalis of the EU Commission and David Feigal, former FDA Commissioner, proved […]

By John Wilkinson Former Chief Executive of Eucomed

Welcome
Business Value

Posted on 12.03.2009

Welcome to the Eucomed blog…

Hello and welcome to the Eucomed blog. This is the place to find out about the latest news on all aspects of medical technology, from financing of healthcare to European regulation. You will also be able to read short reports of events attended by Eucomed staff. We have put together a team of bloggers, each […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed